<DOC>
	<DOCNO>NCT01632137</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety rebamipide ophthalmic suspension subject dry eye syndrome .</brief_summary>
	<brief_title>Efficacy Safety Rebamipide Subjects With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>History dry eyerelated ocular symptom least 20 month . Meet protocoldefined criterion corneal conjunctival staining . Meet protocoldefined criterion ocular discomfort . Active anterior segment ocular disease dry eye syndrome . Inability suspend use topical ophthalmic medication throughout duration study . Inability suspend use contact lenses duration study . Judged investigator ineligible study past concurrent systemic disease , safety concern . Received investigational product within 4 month screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>